1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. GSK PLC - ADR
GSK Plc - ADR
XNYS: GSK
Await Turnaround
Download real time
50.22 -0.84 (-1.65%)
27.82% Gain from 52W Low
4.7M
XNYS Volume

XNYS 18 Sep, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Acquisition
GSK to acquire Chimagen's experimental blood cancer drug in deal worth up to $750 million See details

GSK PLC (ADR) - GSK - stock price prediction, stock price target, analyst ratings from 8 analysts

GSK PLC (ADR) has a share price target of US$ 59, revenue growth forecast of 3.2%, and profit growth estimate of -7.0% for FY26, based on top 8 analyst calls.

Forecaster Screeners